Related references
Note: Only part of the references are listed.Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics
Yoon Seong Choi et al.
NEURO-ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma
Minjae Kim et al.
EUROPEAN RADIOLOGY (2020)
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
Annette M. Molinaro et al.
JAMA ONCOLOGY (2020)
Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
Jinhyun Choi et al.
SCIENTIFIC REPORTS (2020)
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016
Roberta Ruda et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system
Daniel Delev et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
IDH mutation-specific radiomic signature in lower-grade gliomas
Xing Liu et al.
AGING-US (2019)
Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients
Kai Wang et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis
Maarten M. J. Wijnenga et al.
NEURO-ONCOLOGY (2018)
The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas
Toral Patel et al.
NEUROSURGERY (2018)
A surgical strategy for lower grade gliomas using intraoperative molecular diagnosis
Shunichi Koriyama et al.
BRAIN TUMOR PATHOLOGY (2018)
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature
Yiming Li et al.
EUROPEAN RADIOLOGY (2018)
MRI features predict p53 status in lower-grade gliomas via a machine-learning approach
Yiming Li et al.
NEUROIMAGE-CLINICAL (2018)
Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas
Yuqi Han et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study
Xiaojie Ding et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival
Chikezie I. Eseonu et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy
Federico Pessina et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
Michael Weller et al.
ACTA NEUROPATHOLOGICA (2015)
Genome-wide transcriptional analyses of Chinese patients reveal cell migration is attenuated in IDH1-mutant glioblastomas
Huimin Hu et al.
CANCER LETTERS (2015)
Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis
Saleh A. Almenawer et al.
NEURO-ONCOLOGY (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The impact of extent of resection on malignant transformation of pure oligodendrogliomas
Laura A. Snyder et al.
JOURNAL OF NEUROSURGERY (2014)
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
Jason Beiko et al.
NEURO-ONCOLOGY (2014)
New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951
Thierry Gorlia et al.
EUROPEAN JOURNAL OF CANCER (2013)
Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas
Asgeir S. Jakola et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors
Tejas Sankar et al.
JOURNAL OF NEUROSURGERY (2012)
Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients Clinical article
Maurizio Salvati et al.
JOURNAL OF NEUROSURGERY (2012)
The Value of Glioma Extent of Resection in the Modern Neurosurgical Era
Douglas A. Hardesty et al.
Frontiers in Neurology (2012)
Low-grade gliomas in adults
Nader Sanai et al.
JOURNAL OF NEUROSURGERY (2011)
Dynamic history of low-grade gliomas before and after temozolomide treatment
Damien Ricard et al.
ANNALS OF NEUROLOGY (2007)
Share Paper
